Uptrend Under Pressure 100
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 100/100 · 7 distribution days (SPY) Oct 26 Full briefing →
View
Simple research view

PFE · Pfizer, Inc.

$29.79 -0.80% Oct 26 close
Detected setup Trend Only · Setup Score 90/100

Stand aside — setup invalidated

Setup score 90, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about PFE

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$PFE

Pfizer, Inc.

Pfizer, Inc. is a large-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $170B.

Health Technology Pharmaceuticals: Major stock Stage 2 · Advancing Base 1
$29.79 latest close
Market Structure
Trend structure: range
Latest event: structure_shift (bullish)
Support 24.83–25.27 · 11 touches · strong
Support 26.44–26.65 · 6 touches · strong
Support 27.41–27.67 · 5 touches · strong
Support 25.47–25.65 · 4 touches · moderate
Support 26.19–26.35 · 3 touches · moderate
Join to Watchlist $PFE Share card
Verdict · setup score 90/100 · data Oct 26 close · latest session

Stand aside — setup invalidated

Setup score 90, but distribution days reach 5 or more — stand aside until the condition resets.

Review six verdicts Inspect chart
Recent price action · daily
$25.00$27.50$30.00AugSepOct$29.79

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

  • Minervini 2. Quarterly EPS growth ≥ 25% — +2.7% QoQ
  • Minervini 2. ROE ≥ 17% — ROE 4.9%
  • O'Neil C: Quarterly EPS acceleration ≥ 25% — +2.7% QoQ
  • O'Neil L: RS rank ≥ 80 (IBD leadership) — RS rank 75
  • Weinstein Volume expansion above average — Volume ratio 0.80x
  • Weinstein Weekly price coiling (Stage 2 consolidation) — Tightening weekly range confirms base
Minority view — the council disagrees here
  • Minervini: watch Trend-template read: 7/10 pass; wait for the soft misses to improve.
  • O'Neil: avoid CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
  • Weinstein: watch Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.
64 Neutral
Legend Score · rates the stock Neutral (64/100) — held back by eps growth

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

  • Relative Strength (25%) 76
  • Trend Template (25%) 88
  • Institutional Footprint (20%) 62
  • EPS Growth (15%) 30
  • Quality (SMR-like) (15%) 44

RS rank 75: above-average strength. Trend template 7/8: price above rising 50/150/200-day lines — textbook uptrend structure. Institutional score 62: mild accumulation. EPS up +0% — growing, but below the 25% leadership bar. Quality 44: weak fundamentals (sales growth 30, return on equity 40, leverage 100). Updated 2026-10-27.

Earnings

Pre-earnings setup

Next earnings Monday, November 2, 2026 Report time not confirmed by the source

Deterministic evidence

PFE-0.80%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
Same completed session window ending 2026-10-26. PFE was -0.80 points vs XLV. -1.51 points vs SPY.
CatalystPending Stock reactionNegative Sector reactionWeak Opening surgePending Event riskEarnings-driven

Session internals Weak

Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.

Vs prior close-0.80% From the open-0.70% Range position12% GapNo gap
QQQ confirmationDiverging (+1.11%) SMH confirmationDiverging (+2.74%)
Short-term conviction -2 points.
  • QQQ, SMH moved against the stock — no index confirmation.
  • A sourced earnings report is still pending inside the risk window; ordinary technical conviction is reduced until it is out.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $29.79 -0.8% Oct 26 close
52W High $30.44 2.1% below high
Wks Since High 0w
Base Depth 2.1% 2.4% today
RS Rank 47 percentile of scan
SMA 50 $28.36
Avg Vol 32,085,114
Rel Vol (Oct 26) 0.80× 0.74× on up days
More stats
52W Low $23.62
Tight Wks 4
Base B1
SMA 200 $26.71
RS Line vs High -11.4%
RS Line Slope +3.6% ▲
Group Rank #12/66
ADR% 1.9%
ATR(14) $0.58 (1.9%)
Vol Pace (live) N/A
A/D Days 22A / 9D
A/D Rating A+
VDU Bars 0/10 d
Power Trend 12d
Earnings in 6d
Position in 52-week range 90thpercentile of the 52-week range
$23.62low
$30.44high

PFE Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for PFE.

Create Free Account

Technical Analysis Report Card

$PFE · $29.79 · as of 2026-10-26 · multi-factor read
98
/ 100
Technicals 98/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$28.36 ↑
100-day$26.76 ↑
200-day$26.71 ↑
Bullish (50 > 200)

RSI (14)

Reading61.8 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateBullish
Histogram+0.119

Bullish — MACD above its signal line and above zero. Histogram contracting.

Bollinger Bands (20,2)

%B / Width75% · 13.1%

Mid-band — no directional band edge in play.

Volume · Buyer vs Seller

Up/Down vol0.74 · Neutral
Rel volume0.8×
Pocket pivots · 10d0
5d vs 50d vol85%
Heavy vol up / down0 / 0

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $30.4452-week high
Price · $29.79now
S · $27.64swing level
S · $27.19swing level
S · $26.68swing level

Fibonacci · Uptrend swing

23.6%$28.83
38.2%$27.83
50.0%$27.03
61.8%$26.23
78.6%$25.08

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for PFE — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice? Ask a Legend about PFE
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (90/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 7 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini Watch C Trend-template read: 7/10 pass; wait for the soft misses to improve.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $29.79, MA150 $26.72, MA200 $26.71
1.2 150-day MA > 200-day MAMA150 $26.72 vs MA200 $26.71
Failing evidence
2. Quarterly EPS growth ≥ 25%+2.7% QoQ
2. ROE ≥ 17%ROE 4.9%
7/10 checks
Method → Playbook → Ask →
O'Neil Avoid D CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
Passing evidence
N: Near 52-week high or RS line new high2.1% below high | RS line new high: False
S: Base tightness (ATR% ≤ 4.5%)ATR% 1.95%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%+2.7% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 75
2/8 checks
Method → Playbook → Ask →
Weinstein Watch C Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

mediumClassic Stage 2 advancing phase — strong weekly trend confirms uptrend. This is Weinstein's sweet spot: buy and hold while price remains above the 30-week MA.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $29.79 vs MA200 $26.71
Failing evidence
Volume expansion above averageVolume ratio 0.80x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
5/7 checks
Method → Playbook → Ask →
dennis Watch C Turtle read: no breakout yet. Price is pressing the 20-day high. The system waits for the print; it never anticipates.
Passing evidence
No breakdown below the 20-day channel20-day low $27.12
Volatility-unit sizing (1N ≈ 1% of equity)1N = $0.56 (1.86% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
5/7 checks
Method → Playbook → Ask →
zanger Avoid D Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $34.26-$35.75; trail the rest
Trail on the 10/20-day MA10-day MA $29.62 · 20-day MA $28.84 — exit the remainder on a close below the trail
Failing evidence
Named Zanger pattern onlyTrend Only is not one of Zanger's six
Not extended (≤5% above the breakout point)Data unavailable
3/6 checks
Method → Playbook → Ask →
zweig Watch D Zweig read: part of his screen passes but not all: EPS growth above the market (≥15% QoQ); Insider buying — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 21.9x — no PEG or forward P/E stored
Price strength (RS ≥ 70)RS score 75 — Zweig buys strength, not bargains
Failing evidence
EPS growth above the market (≥15% QoQ)+2.7% QoQ — Zweig wants growth above the S&P average
Insider buyingNo insider buying flagged
4/8 checks
Method → Playbook → Ask →
Livermore Watch B Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$29.79
Relative strengthRS 75
Failing evidence
Volume vs average0.80x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Darvas Watch B Box-theory read: constructive evidence is present, but volume vs average is unresolved.

mediumStock is at the top of its box — Darvas would wait for a decisive breakout on volume.

Passing evidence
Price$29.79
Relative strengthRS 75
Failing evidence
Volume vs average0.80x
Box top broken on heavy volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Wyckoff Watch B Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$29.79
Relative strengthRS 75
Failing evidence
Volume vs average0.80x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
4/6 checks
Method → Playbook → Ask →
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Base & Breakout Tracking
RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
108RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +12 A+
A: 20 D: 8 Net: +1265 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 3/7 met
C 3/7 criteria
Separate score from the Minervini Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ +3%
✗ Revenue growth ≥20% YoY -2%
✓ Gross margin ≥30% 75%
✗ ROE ≥17% 5%
✗ RS rating ≥80 (leadership) 75
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -2.1%

Method Playbook

Trade it like Darvas EXACT LEVELS · PRO
Darvas B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the top of the active Darvas box near the high as the mechanical breakout boundary.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require price to clear the box top with volume confirmation; movement inside the box remains observation, not a trigger.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the active box support or the canonical structural stop that proves the breakout failed.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: As higher boxes form, raise the stop beneath the newest confirmed box floor; the stop moves up only.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit when price breaks the active box floor or decisively falls back through the breakout structure.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

Trend Only
90 setup score
RS Score 75
Trend template 7/8
Why This Setup? D+W Confluence
Trend Only · schematic

Gatekeeper 7/8 | Strong trend (7/8) | Good RS (75) | Power Trend | Stage 2 | Tight base (4 tight wks)

Ask a Legend ▾
The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

1/7 universals met
  • A relative-strength leader — not met RS rank 47 — laggard
  • Clear of earnings — not met in 6 days — event risk
  • Risk is defined — not met No stop — undefined risk
  • Asymmetric reward — partly met No target set
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 0.8× average — light
  • In a confirmed uptrend — met Stage 2 · Trend template 7/8
Why these seven? → The Universal Edge

Minervini Trend Template

7/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $29.79 vs SMA150 $26.72 / SMA200 $26.71
SMA 150 above SMA 200 SMA150 $26.72 vs SMA200 $26.71
SMA 200 trending up Slope +0.35 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $28.36
Price above SMA 50 $29.79 vs SMA50 $28.36
30%+ above 52-week low +26.1% from $23.62
Within 25% of 52-week high -2.1% from $30.44
RS score above 70 RS 75

Fundamentals

52W Range
90%
Mkt Cap SEC
169.8B
EPS QoQ
+3%
Rev YoY
-2%
ROE
5%
Gross Margin
75%
D/E
0.75
EPS TTM
$1.36
P/E TTM
21.9x
Float
5.7B
Insider
No Buy

Company

Company profile
Pfizer, Inc.
PFE · NYSE · Health Technology · Pharmaceuticals: Major
Track all markets on TradingView

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
6/8
W. RS
75
W. Support
$23.62
W. Resist
$30.44
W. Patterns
Cup & Handle Base Breakout Basing
Weekly Structure

Scan History

20× streak
Oct 26: 81 (Cup & Handle)Oct 26: 82 (Cup & Handle)Oct 26: 82 (Cup & Handle)Oct 27: 88 (Trend Only)Oct 27: 90 (Trend Only)Oct 27: 90 (Trend Only)90
Oct 27
Trend Only ✓ Gate
90
Oct 27
Trend Only ✓ Gate
90
Oct 27
Trend Only ✓ Gate
88
Oct 26
Cup & Handle ✓ Gate
82 0.0%
Oct 26
Cup & Handle ✓ Gate
82 0.0%
Oct 26
Cup & Handle ✓ Gate
81 0.0%

Latest News

Headlines for PFE
Loading headlines…

Get the full picture on PFE

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial